For sponsors and CROs, patient engagement is critical. But where to start? This guide explores specific opportunities for sponsors, CROs, and trial sites to develop patient-centric clinical trials for rare diseases.
This comprehensive guide to ISE/ISS content explains what the summaries must include for successful submission.
SOHONOS, the first drug for fibrodysplasia ossificans progressiva, receives US FDA approval with Real-World Evidence as external control
Our experts conducted a deep evaluation of IgG-like bsAbs including general advantages and disadvantages compared with MAbs and more.
Our experts published a series of articles in BioProcess International reviewing the state of the art of Fc – fusion proteins, including their structure and molecular design, manufacturing process and therapeutic uses
Our team explores the effectiveness of Pressure Ulcer Prevention Devices (PUPDs) for at-risk patients following hospital discharge in France.
In the article our team investigated the use of an alternative purification method for BsAbs – a commercially available CaptureSelect CH1-XL affinity resin.
This guide explores specific opportunities for sponsors, CROs, and trial sites to develop patient-centric clinical trials for rare diseases.
Alira Health is proud to announce it has been named by Forbes as one of the World's Best Management Consulting firms for 2023.
Alira Health announced that Gabriele Brambilla, Alira Health’s Chief Executive Officer and Co-Founder, and Piergiulio Lauriano, Chief Strategy Officer at Alira Health, will present at the 35th Annual Piper Sandler Healthcare Conference.
Alira Health and FORWARD announced the launch of the enhanced Lupus Registry, enabling patients, caregivers, and research sponsors to gain better insights, and achieve better patient outcomes.
Alira Health and the Patient Empowerment Network announced their partnership in supporting those impacted by cancer with a mobile platform delivering essential support for their medical needs.
Following Alira Health’s Commercial Due Diligence (CDD), TVM Capital Healthcare has completed a multi-million euro investment in DEBx Medical.
We are pleased to partner with Col·legi de Metges de Barcelona (CoMB), an institution that represents and serves the almost 39,000 physicians in Barcelona.
Alira Health announced today the publication of the Diabetes Management Devices Market Trends 2023, in collaboration with MassMEDIC, the Massachusetts Medical Device Industry Council.
To gain insight on the challenges and typical paths to failure, as well as a wide array of solutions for successful patient recruitment, we spoke with two Alira Health experts, Annabel de Maria, Chief Patient Officer, and Chris Rao, Senior Vice President of Clinical Operations.
Discover the notable trends in the diabetes management devices market including glucose monitoring, insulin delivery and digital health.
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
A hospital-specific NLP-powered platform can identify and characterize patients to provide pharma and biotech companies with fit-for-purpose RWD.
Explore the potential and challenges related to RWE in P&R decision-making for rare disease products in Spain, one of the most attractive markets in Europe because of universal healthcare.
This article explores the relationship between the number of new cancer treatment approvals and the five-year relative survival of cancer patients across the European Union (EU).
In the final article of our Biotech series, Joris Pezzini talks about the evolution of biotechs in the face of challenges and the drivers for future success.
Join a series of educational webinars on Value-Based Contracting led by payers and academic experts.
Explore lupus solutions and real-world treatment impacts through a discussion on patient aspects and the role of technology in streamlining research efficiency.
Join this webinar hosted by France Biotech to learn best practices and how to overcome challenges in engaging patients in your clinical trial.
Kenny Carberry, VP, Business Development, Research & Clinical Development, joins the “Clinical Trials & Hospital Pilots” webinar as speaker.
In this webinar, you’ll learn how to identify key solution features, define patient experience expectations, generate evidence, and more!
Gabriele Brambilla returned to the MedTech World Podcast to discuss the power the CARES Act gives patients over their digital health data.
In this webinar, you’ll learn how to identify key solution features, define patient experience expectations, generate evidence, and more!
